Literature DB >> 21725267

Acquired cholesteatoma: classification and outcomes.

Bruce Black1, Ian Gutteridge.   

Abstract

OBJECTIVE: Reclassification of acquired cholesteatoma into the commonly observed presentations of this condition to provide a simple and clear grouping that indicates the pathology, management, and outcomes of the group cases. PATIENTS: Virgin acquired cholesteatoma cases from a single center managed from 1986 to 2008 (515 cases).
INTERVENTIONS: Cases were managed by transcanal (20%) or intact canal wall techniques. Wall repairs successively used autograft cartilage (transcanal and early intact canal wall mastoidectomy cases), hydroxylapatite plates (1989-2007), or titanium sheeting (2007). Drum repairs used cartilage-perichondrial composite grafts. Assembly techniques were the preferred ossiculoplasty method.
RESULTS: Distribution: attic, 41%; pars tensa, 45%; and combined attic-pars tensa, 14%. Unclassifiable cases (n = 14) were excluded. Contralateral disease was present in 15% and effusions in 34% during or after surgery. Cell formation was most extensive in attic disease, least in combined patterns. Ossicular pathology was worse in the collapsed drum cases. Attic cases had the best hearing outcomes but risked recurrent disease, which required precise countermeasures. Overall, the combined pattern group carried the worst prognosis.
CONCLUSION: Compared with previous methods, the clinical classification proved simple, descriptive, and comprehensive. It provides a readily discerned practical basis for clinical management and research purposes.

Entities:  

Mesh:

Year:  2011        PMID: 21725267     DOI: 10.1097/MAO.0b013e3182255874

Source DB:  PubMed          Journal:  Otol Neurotol        ISSN: 1531-7129            Impact factor:   2.311


  9 in total

1.  All about Imagistic Exploration in Cholesteatoma.

Authors:  Mariana Coman; Alexandru Coman; Dan-Cristian Gheorghe
Journal:  Maedica (Buchar)       Date:  2015-06

2.  Cholesteatoma Classification: Review of Literature and Proposed Indian Classification System-TAMPFIC.

Authors:  M B Bharathi; Pranshu Mehta; Kavya Sivapuram; D Sandhya
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2020-09-29

3.  Clinical Characteristics of Patients with Cochlear Fistulas Caused by Chronic Otitis Media with Cholesteatoma.

Authors:  Woongsang Sunwoo; Sang-Youp Lee; Jeon Seong; Young Eun Han; Min-Hyun Park
Journal:  J Int Adv Otol       Date:  2020-04       Impact factor: 1.017

4.  Computed Tomography Staging of Middle Ear Cholesteatoma.

Authors:  Ahmed Abdel Khalek Abdel Razek; Mohamed Rashad Ghonim; Bassem Ashraf
Journal:  Pol J Radiol       Date:  2015-06-25

5.  Middle ear mucosal regeneration by tissue-engineered cell sheet transplantation.

Authors:  Kazuhisa Yamamoto; Masayuki Yamato; Tsunetaro Morino; Hiroaki Sugiyama; Ryo Takagi; Yuichiro Yaguchi; Teruo Okano; Hiromi Kojima
Journal:  NPJ Regen Med       Date:  2017-03-24

6.  Outpatient management of cholesteatoma with canal wall reconstruction tympanomastoidectomy.

Authors:  Richard Kao; Todd Wannemuehler; Charles W Yates; Rick F Nelson
Journal:  Laryngoscope Investig Otolaryngol       Date:  2017-10-31

7.  Assessing the Prognostic Value of the ChOLE Classification in Predicting the Severity of Acquired Cholesteatoma.

Authors:  Maura C Eggink; Maarten J F de Wolf; Fenna A Ebbens; Frederik G Dikkers; Erik van Spronsen
Journal:  Otol Neurotol       Date:  2022-04-01       Impact factor: 2.311

8.  Mapping the ChOLE classification to hearing outcomes and disease-specific health-related quality of life.

Authors:  Nora M Weiss; David Bächinger; Adrian Rrahmani; Hans E Bernd; Alexander Huber; Robert Mlynski; Christof Röösli
Journal:  Eur Arch Otorhinolaryngol       Date:  2020-05-05       Impact factor: 2.503

9.  Characteristics of 419 patients with acquired middle ear cholesteatoma.

Authors:  Letícia Petersen Schmidt Rosito; Maurício Noschang Lopes da Silva; Fábio André Selaimen; Yuri Petermann Jung; Marcos Guilherme Tibes Pauletti; Larissa Petermann Jung; Luiza Alexi Freitas; Sady Selaimen da Costa
Journal:  Braz J Otorhinolaryngol       Date:  2016-05-03
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.